Advertisement
Advertisement
U.S. markets open in 6 hours 22 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.5500-0.0800 (-1.73%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close4.6300
Open4.6700
Bid0.0000 x 4000
Ask0.0000 x 3100
Day's Range4.4050 - 4.9000
52 Week Range3.8210 - 12.2500
Volume143,406
Avg. Volume45,867
Market Cap31.505M
Beta (5Y Monthly)1.72
PE Ratio (TTM)13.19
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALIM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Alimera Sciences, Inc.
    Analyst Report: AbbVie Inc.AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    15 days agoMorningstar
View more
Advertisement
Advertisement